Report from the Extraordinary General Meeting of IRLAB Therapeutics AB
IRLAB Therapeutics AB held its Extraordinary General Meeting today, Friday, 5 June 2026.The following main resolutions were made at the general meeting.Approval of the Board of Directors' resolutions on issues of new shares of series A, with …
Weiterlesen »